Patents by Inventor Christian Kannemeier

Christian Kannemeier has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Production of virus-receptive pluripotent stem cell (PSC)-derived hepatocytes
    Patent number: 10093903
    Abstract: The present disclosure provides methods for maturing hepatocytes comprising culturing with cyclic adenosine monophosphate and a Janus kinase inhibitor. There is also provided a method for screening inhibitors of hepatitis B virus infection and/or replication.
    Type: Grant
    Filed: October 19, 2016
    Date of Patent: October 9, 2018
    Assignee: FUJIFILM Cellular Dynamics, Inc.
    Inventors: Christian Kannemeier, Elisabeth Enghofer, Lisa Harms
  • PRODUCTION OF VIRUS-RECEPTIVE PLURIPOTENT STEM CELL (PSC)-DERIVED HEPATOCYTES
    Publication number: 20170107485
    Abstract: The present disclosure provides methods for maturing hepatocytes comprising culturing with cyclic adenosine monophosphate and a Janus kinase inhibitor. There is also provided a method for screening inhibitors of hepatitis B virus infection and/or replication.
    Type: Application
    Filed: October 19, 2016
    Publication date: April 20, 2017
    Inventors: Christian KANNEMEIER, Elisabeth ENGHOFER, Lisa HARMS
  • NON-VIRAL DELIVERY OF TRANSCRIPTION FACTORS THAT REPROGRAM HUMAN SOMATIC CELLS INTO A STEM CELL-LIKE STATE
    Publication number: 20120282229
    Abstract: Disclosed herein are cellular compositions, stable continuous cell cultures, reporter cell lines, pharmaceutical preparations, cell penetrable pluripotent stem cells transcription factors and methods related thereto, related to reprogrammed somatic cells.
    Type: Application
    Filed: August 1, 2008
    Publication date: November 8, 2012
    Inventors: Christian Kannemeier, Joel Sae Won Marh, Kyle Howerton, John Sundsmo
  • Pharmaceutical preparation with RNA as hemostasis cofactor
    Publication number: 20080317735
    Abstract: Pharmaceutical preparations which comprise RNA or one or more coagulation-promoting fragments of RNA in amounts sufficient to promote coagulation and to promote fibrinolysis are described.
    Type: Application
    Filed: August 7, 2008
    Publication date: December 25, 2008
    Inventors: Klaus Preissner, Fumie Nakazawa, Christian Kannemeier, Juergen Roemisch
  • Pharmaceutical preparation with RNA as hemostasis cofactor
    Publication number: 20070212344
    Abstract: Pharmaceutical preparations which comprise RNA or one or more coagulation-promoting fragments of RNA in amounts sufficient to promote coagulation and to promote fibrinolysis are described. They are in particular advantageously employed together with an activator for hemostatic processes such as factor VII-activating protease (FSAP).
    Type: Application
    Filed: May 11, 2007
    Publication date: September 13, 2007
    Inventors: Klaus Preissner, Fumie Nakazawa, Christian Kannemeier, Juergen Roemisch
  • Stabilized liquid preparation of the protease which activates blood coagulation factor VII, or of its proenzyme
    Patent number: 7202065
    Abstract: A stabilized liquid preparation of a protease which activates blood coagulation Factor VII or of its proenzyme is herein described. The preparation also contains one or more compounds selected from the group consisting of ornithine, diaminopimelic acid, agmatine, creatine, guanidinoacetic acid, acetylornithine, citrulline, arginoinosuccinic acid, tranexamic acid and epsilon-aminocaproic acid or their salts and has a pH of 2–8.
    Type: Grant
    Filed: January 3, 2002
    Date of Patent: April 10, 2007
    Assignee: ZLB Behring GmbH
    Inventors: Jürgen Römisch, Annette Feussner, Christian Kannemeier, Hans-Arnold Stöhr
  • Pharmaceutical preparation with RNA as hemostasis cofactor
    Publication number: 20050075301
    Abstract: Pharmaceutical preparations which comprise RNA or one or more coagulation-promoting fragments of RNA in amounts sufficient to promote coagulation and to promote fibrinolysis are described.
    Type: Application
    Filed: August 1, 2003
    Publication date: April 7, 2005
    Inventors: Klaus Preissner, Fumie Nakazawa, Christian Kannemeier, Juergen Roemisch
  • Use of coagulation factor VII-activating protease for the prophylaxis and therapy of vasoproliferative disorders
    Publication number: 20030077271
    Abstract: The use of coagulation factor VII-activating protease (FSAP) for the prophylaxis and/or therapy of vasoproliferative disorders or oncoses is described. Reference is made in particular to the use of the protease for retinopathy, neuropathy, rheumatoid arthritis, psoriasis, endometriosis, bronchitis (especially chronic) or chronic inflammations in the gastrointestinal tract.
    Type: Application
    Filed: September 26, 2002
    Publication date: April 24, 2003
    Inventors: Christian Kannemeier, Juergen Roemisch, Klaus T. Preissner, Sandip Kanse
  • Stabilized liquid preparation of the protease which activates blood coagulation factor VII, or of its proenzyme
    Publication number: 20020110552
    Abstract: A stabilized liquid preparation of the protease which activates blood coagulation factor VII, or of its proenzyme, which comprises;
    Type: Application
    Filed: January 3, 2002
    Publication date: August 15, 2002
    Inventors: Jurgen Romisch, Annette Feussner, Christian Kannemeier, Hans-Arnold Stohr